Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
about
Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide.Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer.Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.Targeting polymer therapeutics to bone.Mucoadhesive fenretinide patches for site-specific chemoprevention of oral cancer: enhancement of oral mucosal permeation of fenretinide by coincorporation of propylene glycol and menthol.Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring.Drug-releasing shape-memory polymers - the role of morphology, processing effects, and matrix degradation.Polymeric drug delivery systems for intraoral site-specific chemoprevention of oral cancer.Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.Analysis of fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics.Alginate Microencapsulation for Oral Immunisation of Finfish: Release Characteristics, Ex Vivo Intestinal Uptake and In Vivo Administration in Atlantic Salmon, Salmo salar LDegradation Behavior of Porous Copolyester Microparticles in the Light of Dynamic Changes in Their MorphologyEncapsulation of nor-β-lapachone into poly(d,l)-lactide--glycolide (PLGA) microcapsules: full characterization, computational details and cytotoxic activity against human cancer cell linesNanoparticles combined with growth factors: recent progress and applications
P2860
Q34829200-DED6B973-E050-43C3-876B-C0F9077293CCQ35209424-D9B5FB04-BE8D-4937-8282-3A733AB9AA17Q35307851-C7E686AA-69FD-4E25-BABB-09AC98AE7A71Q35706314-674E8ED6-C9B6-4A99-8292-3D76A4B396EDQ35951743-4180D733-98FB-4EBD-8640-E90E87CA7A89Q36942385-40F51216-9856-45C2-876E-1ADBCF434EBFQ37663640-82E8A042-405C-4B2C-BD1C-5ED88D7D0007Q38106195-46197501-6415-4939-BE30-66CEF71FFBE3Q39398234-776A0D18-6D15-4438-9E1D-EFF357648075Q47958009-0DF877B8-5A6C-4AF1-BFB2-12395C54AF16Q50283738-4DF86483-CDB8-46A6-85C0-91175ADF2674Q56968027-CA6B62A6-5A60-4D03-B0BD-EFF370F0AB30Q56979429-51C7A1CA-7D6B-4F82-BAB0-2A01287ACD90Q57150128-C8097BD5-2482-4DCC-9B8C-D9DD64878047Q57377197-7B794762-FD8E-48F5-8AEA-2DAB048CDA48
P2860
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
@en
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
@nl
type
label
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
@en
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
@nl
prefLabel
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
@en
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
@nl
P2093
P2860
P1476
Development of PLGA-based injectable delivery systems for hydrophobic fenretinide
@en
P2093
Sachin Mittal
Steven P Schwendeman
Ying Zhang
P2860
P304
P356
10.1007/S11095-010-0202-Y
P577
2010-07-29T00:00:00Z